The phrase "active in a population" is correct and usable in written English.
It can be used in contexts related to biology, ecology, or social sciences to describe individuals or entities that are engaged or participating within a specific group or community.
Example: "The researchers found that certain species were more active in a population during the breeding season."
Alternatives: "engaged in a population" or "participating in a population".
Indeed, achieving control of percentage active in a population without introducing heterogeneity requires modulating duration of a high-dose input.
The PRSx8 promoter is also active in a population of noradrenergic neurones (A2 cell group) of the nucleus of the solitary tract located dorsal to the DVMN.
The Cre driver was found to be active in a population of progenitor cells (as defined by absence of expression of cardiac Troponin T (cTnT) but presence of proliferation markers and the embryonic CM transcription factors Gata4 and Tbx5).
Different genes show reproducible frequency (between experimental replicates and among individuals) of 2X-active and 1X-active nuclei in a population of female fibroblast cells.
In addition, ARTI trends have been used to assess the impact of the HIV epidemic on TB transmission [3], [4] although it is still argued that the risk of infection in children allows little insight on the impact that HIV may exert on the burden of active tuberculosis in a population [5].
Timely sample collection during active exposure, in a population with a wide range of exposure, may increase power to detect effects even in small studies.
Celecoxib, in conjunction with erlotinib and reirradiation, was shown to be a feasible and clinically active regimen in a population of patients with recurrent HNSCC who had a poor prognosis (Jaeckel et al, 2001).
A preventive treatment of infected but asymptomatic individuals lowers the risk of reactivation of latent infection and therefore decreases the pool of future active tuberculosis in a population [ 3].
Thus, the PSUMMIT 2 trial data through week 60 indicate that ustekinumab, representing an alternate mechanism of action to approved biological PsA therapies, induced significant improvement in the joint, enthesitis/dactylitis and skin symptoms of active PsA in a population including ∼58% anti-TNF-experienced patients, with an acceptable safety profile.
To assess the effect of simvastatin as a single agent and in combination with purine analogs on non-leukemic cells, we measured the percentage of apoptotic cells with the expression of active caspase-3 in a population of CD19+/CD5− and CD19−/CD5+ cells, which represented B and T cells, respectively.
In summary, the present study, EGF109491, demonstrates that the combination of lapatinib plus capecitabine is active and well-tolerated in a population of Chinese women with HER2-positive advanced breast cancer or MBC who have progressed following other treatments, including an anthracycline and/or a taxane, with or without trastuzumab.
